Veteran biopharmaceutical and oncology leader brings more than three decades of experience across clinical development, regulatory, and ...
Mo-Rez achieved confirmed objective response rates of 62% in patients with platinum-resistant ovarian cancer. Credit: MMD ...
Prostate cancer is one of the most prevalent malignancies in men and remains a leading cause of cancer-related morbidity and mortality worldwide. For many, prostate cancer follows an indolent course, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results